fashion -WSS

fashion

author：knowledge 2025-09-27 12:58:43 - browse：151

A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT — A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

Next stop: Beacon Hill.

Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： There's an unseen cost to disruptive road

WSS

Vertigo drug brings hope for rare neuron disorder, Niemann

Cardiologists urge adding sexual orientation, gender identity to health records

Congressmen charge Covid hearing ‘could have been an email’

Prior authorization reform is both possible and imperative

Even great ERs can’t make up for American health disparities

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

entertainment

fashion

Wikipedia

Activists slam private health insurers over coverage restrictions

Apple Vision Pro: A first look at health apps on the new VR headset

23andMe had bad news about my health. I wish a person had delivered it

Dana Farber says 6 studies to be retracted and 31 corrected

The high cost of giving birth even with insurance

What we need to know about Arena Bioworks

Dobbs anniversary: the lost opportunity of abortion as health care

Microsoft launches AI tool for clinical documentation through Epic

After affirmative action ruling, medical educators look to 'holistic review'

High breast density mammograms need follow

hotspot

What causes osteoarthritis? Researchers study link to brain protein

FDA drug safety: Singulair case shows systemic surveillance flaws

Inaction leaves children at risk from dangerous chemotherapy drug

What we need to know about Arena Bioworks

Maisha Meds is a PBM, but don't call it that

Dana Farber says 6 studies to be retracted and 31 corrected

entertainment

entertainment

entertainment

focus